Connexius ADC Development & Manufacturing Asia 2028

Antibody-drug conjugates (ADCs) are becoming one of the most dynamic areas of oncology drug development, combining the targeting precision of monoclonal antibodies with highly potent therapeutic payloads. Across Asia, growing investment in ADC discovery, novel linker-payload technologies, bioconjugation and specialised manufacturing is creating new opportunities to develop differentiated therapies while addressing increasingly complex challenges around CMC, analytics, scale-up and commercial manufacturing.

Asia is already playing an increasingly important role in the global ADC ecosystem. South Korea has developed a strong combination of ADC innovation and manufacturing capability, with companies such as LigaChem Biosciences advancing proprietary ADC technologies and Samsung Biologics establishing dedicated ADC manufacturing capabilities in Songdo. In China, companies including RemeGen, DualityBio and Kelun-Biotech have built growing ADC pipelines and international partnerships, while Japan's Daiichi Sankyo has demonstrated the global potential of Asian ADC innovation through its DXd ADC technology and portfolio.

Taking place in Seoul, South Korea, Connexius ADC Development & Manufacturing Asia 2028 will bring together ADC developers, biopharma and biotech companies, CDMOs, research organisations and technology providers from South Korea, Japan, China, Singapore, India and across the wider Asia-Pacific region. The conference will connect expertise across ADC discovery and design, antibody engineering, linker and payload development, conjugation, analytical development, CMC, process development, HPAPI containment, scale-up and manufacturing.

From designing the next generation of ADCs to overcoming the challenges of producing them at commercial scale, the conference will provide a focused platform for the Asian ADC community to exchange technical expertise, discover enabling technologies and build new industry partnerships — supporting the continued growth of Asia as a major hub for ADC development and manufacturing.